期刊文献+

白细胞介素-17和白细胞介素-22在大疱性类天疱疮患者皮损及血清中的表达与意义

The expression and significance of IL-17,IL-22 in the skin lesions and serum of patients with bullous pemphigoid
下载PDF
导出
摘要 目的检测分析大疱性类天疱疮(BP)患者皮损及血清中白细胞介素(IL)-17和IL-22的表达情况,并探讨其在BP发病机制中的意义。方法选取41例BP患者皮损组织(BP组)及25名健康人正常皮肤组织(对照组),用免疫组化方法检测IL-17和IL-22的表达情况。采用酶联免疫吸附试验(ELISA)检测27例BP患者血清中IL-17和IL-22的水平,并以25名健康人作为对照。结果BP组患者皮损中IL-17和IL-22的表达均明显高于对照组,差异有统计学意义(均P<0.01)。且BP组患者皮损组织中IL-17与IL-22的表达呈正相关性。BP组患者血清中IL-17和IL-22的表达水平均高于对照组,差异有统计学意义(均P<0.01)。BP组患者血清中IL-17与IL-22的表达呈正相关性。结论BP患者血清及皮损IL-17和IL-22的表达水平上调,可能参与BP的发病,且两者可能起协同作用。提示3型固有淋巴细胞(ILC3)可能参与BP的致病过程。 Objective To investigate the expression levels of IL-17 and IL-22 in patients with bullous pemphigoid(BP)and explore their significance in the pathogenesis of BP.Methods Using immunohistochemical methods to detect the expression of IL-17 and IL-22 in the skin lesions of 41 BP patients and 25 normal skin tissue(the control group).Additionally,the ELISA method was employed to detect the expression of IL-17 and IL-22 in the serum of 27 BP patients and 25 healthy individuals.Results The expression of IL-17 and IL-22 in the skin lesions of BP patients were significantly higher than that in the control group,with statistically significant differences(P<0.01).Furthermore,a positive correlation was observed between the expression of IL-17 and IL-22 in the skin lesions of BP patients.The expression levels of IL-17 and IL-22 in the serum of BP patients were also higher than those in the control group,with statistically significant differences(P<0.01).A positive correlation was found between the expression of IL-17 and IL-22 in the serum of BP patients.Conclusions The expression levels of IL-17 and IL-22 are significantly elevated in both the serum and skin lesions of BP patients,suggesting their potential involvement in the pathogenesis of BP,possibly through a synergistic mechanism.Additionally,innate lymphoid cells 3(ILC3)may also be involved in the pathogenesis of BP.
作者 崔瑜 吴远慧 胡彩霞 王文氢 张燕 高顺强 CUI Yu;WU Yuanhui;HU Caixia;WANG Wenqing;ZHANG Yan;GAO Shunqiang(Department of Dermatology,the Fourth Hospital of Hebei Medical University,Shijiazhuang 050000,China)
出处 《实用皮肤病学杂志》 2024年第1期25-29,47,共6页 Journal of Practical Dermatology
基金 河北省医学科学研究重点课题计划项目(20230941)。
关键词 类天疱疮 大疱性 白细胞介素-17 白细胞介素-22 固有淋巴细胞 Pemphigoid,bullous IL-17 IL-22 ILCs
  • 相关文献

参考文献7

二级参考文献50

  • 1Dong C.Diversification of T-helper-cell lineages:finding the family root of IL-17-producing cells.Nat Rev Immunol,2006,6:329-333.
  • 2Zheng Y,Danilenko DM,Valdez P,et al.lnterleukin-22,a T(H)17 cytokine,mediates IL-23-induced dermal inflammation and acanthosis.Nature,2007,445:648-651.
  • 3Chen Z,Tato CM,Muul L,et al.Distinct regulation of interleukin-17 in human T helper lymphocytes.Arthritis Rheum,2007,56:2936-2946.
  • 4Yoshida H,Yoshiyuki M.Regulation of immune responses by interleukin-27,Immunol Rev,2008,226:234-247.
  • 5Sugimoto K,Ogawa A,Mizoguchi E,et al.IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis.J Clin Invest,2008,118:534-544.
  • 6Scriba TJ,Kahdorf B,Abrahams DA,et al.Distinct,specific ILl7-and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response.J Immunol,2008,180:1962-1970.
  • 7Sugiyama N,Nakashima H,Yoshimura T,et al.Amelioration of human lupus-like phenotypes in MRL/Ipr mice by overexpression of interleukin 27 receptor α (WSX-1).Ann Rheum Dis,2008,67:1461-1467.
  • 8Wojnarowska F,Kirtschig G,Highet AS,et al.Guidelines for the management of bullous pemphigoid.Br J Dermatol,2002,147 (2):214-221.
  • 9Guillaume JC,Vaillant L,Bernard P,et al.Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid.Arch Dermatol,1993,129 (1):49-53.
  • 10Chosidow O,Saada V,Diquet B,et al.Correlation between the pretreatment number of blisters and the time to control bullous pemphigoid with prednisone 1 mg/kg/day.Br J Dermatol,1992,127(2):185-186.

共引文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部